Regeneron CEO sees new blockbusters on horizon, shuns talk of selling
This article was originally published in Scrip
Executive Summary
Regeneron Pharmaceuticals CEO Leonard Schleifer is fond of saying his biotech company is an “overnight success story” that took more than two decades to build.